Trigonelline Hydrochloride (CAS No 6138-41-6) is a compound commonly studied in the field of biomedical research due to its potential therapeutic benefits and origins in plants such as fenugreek It operates through mechanisms involving modulation of glucose metabolism and the inhibition of protein glycation impacting pathways related to diabetes and neurodegenerative diseases In vitro activity assessments frequently indicate efficacy in the nanomolar to low micromolar range showcasing its potential as a bioactive agent Typical applications include its use in various cell models to study cellular metabolism as well as in animal studies for evaluating potential treatments for metabolic disorders It is also employed in drug screening panels to identify compounds that could mitigate oxidative stress Experimental concentrations typically depend on the specific research design reflecting its diverse applicability and the ongoing exploration of its pharmacological properties